Expanded Access Program of Bitopertin For Participants With EPP or XLP | MicrobiomeTrials← Back to trialsNCT07603401
Expanded Access Program of Bitopertin For Participants With EPP or XLP
AVAILABLEEXPANDED_ACCESS
Trial Details
Locations- University of Miami Miller School of Medicine, Miami, Florida, United States
- MetroBoston Clinical Partners, Boston, Massachusetts, United States
- Mount Sinai Hospital, New York, New York, United States
- Wake Forest University, Winston-Salem, North Carolina, United States
Other microbiome trials you might be interested in
Erythropoietic Protoporphyria
The purpose of this study is to evaluate the concentration of afamelanotide in serum after the administration of afamela…
Leuven, BelgiumCompleted Oct 28, 2024
Erythropoietic Protoporphyria
This is an open-label, long-term extension study to investigate the safety, tolerability and efficacy of DISC-1459 in pa…
Birmingham, United StatesCompleted Jun 2028